Fulcrum Therapeutics Inc (FULC)
EBITDA Margin
-0.51%
TTM · Period ending:
FULC EBITDA Margin
Latest reported-0.51%period ending
Latest reported-0.51%period ending
FULC TTM EBITDA Margin (-8444.13% → -0.51%)
TTM ebitda margin
High-resolution chart · PNG
FULC ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -0.5125% | |
| -11.8738% | |
| -21.6988% | |
| -22.4672% | |
| -3,878.1275% | |
| -3,392.6203% | |
| -3,754.6774% | |
| -3,224.7125% | |
| -2,677.5278% | |
| -1,726.3482% | |
| -979.2627% | |
| -703.2972% | |
| -514.7236% | |
| -408.9965% | |
| -395.892% | |
| -465.9188% | |
| -524.1409% | |
| -784.6764% | |
| -1,474.1627% | |
| -2,389.8909% | |
| -8,444.1332% |